{"url_path":"/sec/alzn/8-k/2026-07-21/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 ****Financial Statements and Exhibits**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-21","source_url":"https://www.sec.gov/Archives/edgar/data/1677077/0001214659-26-008772-index.html","accession_number":"0001214659-26-008772","cik":"0001677077","ticker":"ALZN","issuer_name":"Alzamend Neuro, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1677077/0001214659-26-008772-index.html","primary_entity_key":"0001677077","primary_entity_name":"Alzamend Neuro, Inc."},"word_count":97,"has_tables":true,"body_markdown":"**Item 9.01****Financial Statements and Exhibits**\n\n** **\n\n**(d)****Exhibits:**\n\n \n\n**Exhibit No. **\n \n**Description**\n\n101\n \nPursuant to Rule 406 of Regulation S-T, the cover page is formatted in Inline XBRL (Inline eXtensible Business Reporting Language).\n\n \n \n \n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101).\n\n \n\n 2 \n\n \n\n** **\n\n**SIGNATURE**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934,\nthe registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n**ALZAMEND NEURO, INC.**\n \n\n \n \n \n\n \n \n \n\nDated: July 21, 2026\n/s/ Henry Nisser\n \n\n \n\nHenry Nisser\n\nExecutive Vice President and General Counsel"}